Skip to main content

PET/CT: Combining Function and Morphology

  • Conference paper
Molecular Imaging

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 49))

  • 978 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • ACS ACS: Cancer Facts & Figures 2001. American Cancer Society, National Home Office, Atlanta, pp 1–44

    Google Scholar 

  • Adams S, Baum RP, Stuckensen T, et al. (1998) Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260

    Article  PubMed  CAS  Google Scholar 

  • Bailet JW, Abemayor E, Jabour BA, et al. (1992) Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281–288

    PubMed  CAS  Google Scholar 

  • Bangerter M, Moog F, Buchmann I, et al. (1998) Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease. Ann Oncol 9:1117–1122

    Article  PubMed  CAS  Google Scholar 

  • Burger C, Goerres G, Schoenes S, et al. (2002 a) PET attenuation coefficients from CT images: experimental evaluation of the transformation of CT into PET 511-keV attenuation coefficients. Eur J Nucl Med Mol Imaging 29:922–927

    Article  PubMed  CAS  Google Scholar 

  • Burger I, Goerres GW, Von Schulthess GK, et al. (2002b) PET/CT: Diagnostic improvement in recurrent colorectal carcinoma compared to PET alone. Radiology 225:424

    Google Scholar 

  • Ciernik IF, Dizendorf E, Baumert BG, et al. (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study. International Journal of Radiation Oncology Biology Physics 57:853–863

    Google Scholar 

  • DeGrado TR, Coleman RE, Wang S, et al. (2001) Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. Cancer Res 61:110–117

    PubMed  CAS  Google Scholar 

  • Delbeke D, Vitola JV, Sandier MP, et al. (1997) Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38:1196–1201

    PubMed  CAS  Google Scholar 

  • Dizendorf EV, Baumert BG, von Schulthess GK, et al. (2003) Impact of whole-body F-18-FDG PET on staging and managing patients for radiation therapy. J Nucl Med 44:24–29

    PubMed  Google Scholar 

  • Falk PM, Gupta NC, Thorson AG, et al. (1994) Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 37:153–156

    Article  PubMed  CAS  Google Scholar 

  • Flamen P, Stroobants S, Van Cutsem E, et al. (1999) Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 17:894–901

    PubMed  CAS  Google Scholar 

  • Goerres GW, Schmid DT, von Schulthess GK, et al. (2003) FDG PET/CT improves the confidence of anatomic assignment of cancer lesions in the head and neck: a comparison with FDG PET and contrast-enhanced CT. J Nucl Med 44:417–zzz

    Google Scholar 

  • Goldberg RM, Fleming TR, Tangen CM, et al. (1998) Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med 129:27–35

    PubMed  CAS  Google Scholar 

  • Gupta NC, Maloof J, Gunel E (1996) Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 37:943–948

    PubMed  CAS  Google Scholar 

  • Hany TF, Steinert HC, Goerres GW, et al. (2002) PET diagnostic accuracy: improvement with in-line PET-CT system: initial results. Radiology 225:575–581

    Article  PubMed  Google Scholar 

  • Higashi K, Ueda Y, Seki H, et al. (1998) Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med 39:1016–1020

    PubMed  CAS  Google Scholar 

  • Huang SC, Phelps ME, Hoffman EJ, et al. (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238:E69–E82

    PubMed  CAS  Google Scholar 

  • Jaszczak RJ, Hoffman ED (1995) Positron Emission Tomography (PET): scatter and attenuation, in Wagner HN, Szabo Z, Buchanan JW (eds): Principles of nuclear medicine, 2nd edn. WB Saunders, Philadelphia

    Google Scholar 

  • Jerusalem G, Beguin Y, Fassotte MF, et al. (2000) Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin’s lymphoma. Haematologica 85:613–618

    PubMed  CAS  Google Scholar 

  • Jerusalem G, Beguin Y, Fassotte MF, et al. (1999) Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin’s disease and non-Hodgkin’s lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood 94:429–433

    PubMed  CAS  Google Scholar 

  • Jerusalem G, Hustinx R, Beguin Y, et al. (2002) The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Ann Oncol 13:227–234

    PubMed  Google Scholar 

  • Kau RJ, Alexiou C, Laubenbacher C, et al. (1999) Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 125:1322–1328

    PubMed  CAS  Google Scholar 

  • Kinahan PE, Townsend DW, Beyer T, et al. (1998) Attenuation correction for a combined 3D PET/CT scanner. Med Phys 25:2046–2053

    Article  PubMed  CAS  Google Scholar 

  • Lardinois D, Weder W, Hany TF, et al. (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507

    Article  PubMed  Google Scholar 

  • Moog F, Bangerter M, Kotzerke J, et al. (1998a) 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 16:603–609

    PubMed  CAS  Google Scholar 

  • Moog F, Bangerter M, Diederichs CG, et al. (1998b) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475–481

    PubMed  CAS  Google Scholar 

  • Moog F, Bangerter M, Diederichs CG, et al. (1997) Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging. Radiology 203:795–800

    PubMed  CAS  Google Scholar 

  • Namdar M, Hany TF, Burger C, et al. (2003) Combined computed tomography-angiogram and positron emission tomography perfusion Imaging for assessment of coronary artery disease in a novel PET/CT: a pilot feasibility study. J Am Coll Cardiol 41:439A

    Article  Google Scholar 

  • Patz EF, Jr, Lowe VJ, Hoffman JM, et al. (1993) Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 188:487–490

    PubMed  Google Scholar 

  • Patz EF, Jr, Lowe VJ, Hoffman JM, et al. (1994) Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 191:379–382

    PubMed  Google Scholar 

  • Phelps ME (1981) Positron computed tomography studies of cerebral glucose metabolism in man: theory and application in nuclear medicine. Semin Nucl Med 11:32–49

    Article  PubMed  CAS  Google Scholar 

  • Ruers TJ, Langenhoff BS, Neeleman N, et al. (2002) Value of positron emission tomography with [F-18] fluorodeoxyglucose in patients with colorec-tal liver metastases: a prospective study. J Clin Oncol 20:388–395

    Article  PubMed  CAS  Google Scholar 

  • Schaefer NG, Hany TF, Taverna C, et al. (2003) FDG PET/CT versus contrast enhanced CT in aggressive non-Hodgkin lymphoma and Hodgkin’s disease. J Nucl Med 44:272

    Google Scholar 

  • Stokkel MP, Moons KG, ten Broek FW, et al. (1999) 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 86:2370–2377

    Article  PubMed  CAS  Google Scholar 

  • Stumpe KD, Urbinelli M, Steinert HC, et al. (1998) Whole-body positron emission tomography using fluorodeoxyglucose for staging of lymphoma: effectiveness and comparison with computed tomography. Eur J Nucl Med 25:721–728

    Article  PubMed  CAS  Google Scholar 

  • Webb WR, Gatsonis C, Zerhouni EA, et al. (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178:705–713

    PubMed  CAS  Google Scholar 

  • Webb WR, Sarin M, Zerhouni EA, et al. (1993) Interobserver variability in CT and MR staging of lung cancer. J Comput Assist Tomogr 17:841–846

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Hany, T.F., von Schulthess, G.K. (2005). PET/CT: Combining Function and Morphology. In: Bogdanov, A.A., Licha, K. (eds) Molecular Imaging. Ernst Schering Research Foundation Workshop, vol 49. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26809-X_5

Download citation

  • DOI: https://doi.org/10.1007/3-540-26809-X_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21021-4

  • Online ISBN: 978-3-540-26809-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics